SCHEMBL4484774

SCHEMBL4484774

FC(F)(F)c1ccc(Cl)cc1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TMPRSS4 Q9NRS4 3/20 0.39
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
NOTUM Q6P988 1/20 0.38
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTP4A3 O75365 1/20 0.36
PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30160661 0.82 RAB9A (0.46) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL951322 0.82 RAB9A (0.46) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL3789153 0.78 CYP3A4 (0.52) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL21718747 0.77 MAPK1 (0.41) CYP1A2CYP3A4TSHRMAPK1TDP1
SCHEMBL3842171 0.76 GLA (0.33) TSHRNOTUM
SCHEMBL29403188 0.76 TSHR (0.62) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL107751 0.76 TSHR (0.62) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL3919252 0.74 KIF11 (0.48) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL30898355 0.74 KIF11 (0.48) RAB9ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL18313286 0.74 IDO1 (0.41) TSHRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572805-B2 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-11 US disclosed
EP-1778225-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS Bristol-Myers Squibb Company (US) 2007-05-02 EP disclosed
WO-2006019886-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands HTR2B, OPRD1, HTR1B RAB9A 739/4885CYP1A2 1780/4885CYP2D6 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.